Molecular factors governing inhibition of arylimidamides against Leishmania: conservative computational modeling to improve chemotherapies.
about
Novel amidines and analogues as promising agents against intracellular parasites: a systematic reviewEvaluation of arylimidamides DB1955 and DB1960 as candidates against visceral leishmaniasis and Chagas' disease: in vivo efficacy, acute toxicity, pharmacokinetics, and toxicology studiesSynthesis, DNA binding and antileishmanial activity of low molecular weight bis-arylimidamides.Structure-dependent binding of arylimidamides to the DNA minor groove.Antileishmanial Efficacy and Pharmacokinetics of DB766-azole Combinations.
P2860
Molecular factors governing inhibition of arylimidamides against Leishmania: conservative computational modeling to improve chemotherapies.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular factors governing in ...... ing to improve chemotherapies.
@ast
Molecular factors governing in ...... ing to improve chemotherapies.
@en
type
label
Molecular factors governing in ...... ing to improve chemotherapies.
@ast
Molecular factors governing in ...... ing to improve chemotherapies.
@en
prefLabel
Molecular factors governing in ...... ing to improve chemotherapies.
@ast
Molecular factors governing in ...... ing to improve chemotherapies.
@en
P2093
P2860
P1476
Molecular factors governing in ...... ing to improve chemotherapies.
@en
P2093
Catharine J Collar
David W Boykin
Karl Werbovetz
W David Wilson
Xiaohua Zhu
P2860
P304
P356
10.1016/J.BMC.2011.06.026
P407
P577
2011-06-16T00:00:00Z